N0821: A phase II first-line study of a combination of pemetrexed (P), carboplatin (C), and bevacizumab (B) in elderly patients with good performance status (PS < 2)
- Citation:
- J Clin Oncol vol 30 (15 suppl) abstr 7555
- Meeting Instance:
- ASCO 2012
- Year:
- 2012
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 2071
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- G. K. Dy J. Molina Y. Qi R. H. Ansari S. Thomas H. J. Ross J. Meyers S. Mandrekar A. A. Adjei
- Networks:
- Study
- NCCTG-N0821
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: